Clinical Trials List
2023-05-08 - 2027-07-02
Phase III
Not yet recruiting5
ICD-10I50.20
Unspecified systolic (congestive) heart failure
ICD-10I50.21
Acute systolic (congestive) heart failure
ICD-10I50.22
Chronic systolic (congestive) heart failure
ICD-10I50.23
Acute on chronic systolic (congestive) heart failure
ICD-10I50.30
Unspecified diastolic (congestive) heart failure
ICD-10I50.31
Acute diastolic (congestive) heart failure
ICD-10I50.32
Chronic diastolic (congestive) heart failure
ICD-10I50.33
Acute on chronic diastolic (congestive) heart failure
ICD-10I50.40
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.41
Acute combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.42
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.43
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.9
Heart failure, unspecified
ICD-9428.0
Congestive heart failure
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yung-Ta Kao 無
- 詹超舜 Division of Cardiovascular Diseases
- Chien-Yi Hsu 無
- 鄭宇倫 Division of Cardiovascular Diseases
- Tsung-Lin Yang 無
- 蕭卜源 Division of Cardiovascular Diseases
- Chun-Ming Shih 無
- 陳志維 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tse-Min Lu Division of Cardiovascular Diseases
- Tze-Fan Chao Division of Cardiovascular Diseases
- 李慶威 Division of Cardiovascular Diseases
- 黃少嵩 Division of Cardiovascular Diseases
- 郭泠 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- 吳承學 Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- 廖若男 Division of Cardiovascular Diseases
- Chern-En Chiang Division of Cardiovascular Diseases
- Hao-min Cheng Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 蔡依霖 Division of Cardiovascular Diseases
- Kang-Ling Wang Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 洪國竣 Division of Cardiovascular Diseases
- 周星賢 Division of Cardiovascular Diseases
- 蕭富致 Division of Cardiovascular Diseases
- 謝明哲 Division of Cardiovascular Diseases
- 李廣祚 無
- 張伯丞 Division of Cardiovascular Diseases
- 謝侑叡 Division of Cardiovascular Diseases
- 葉勇信 Division of Cardiovascular Diseases
- 沃宏達 Division of Cardiovascular Diseases
- 葉日凱 Division of Cardiovascular Diseases
- 董穎璋 Division of Cardiovascular Diseases
- 陳東藝 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Po-Chao Hsu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
4900 participants
